At the laboratory, the samples are tested for SARS-CoV-2, the virus that causes COVID-19, as well as certain strains of influenza. Some results are received in as little as 24 hours.
Dr. Bero explains: “Before cases start circulating in the community, we already know that it is agent “X” that is circulating... and we can easily take preventative measures.”
Beginning next year, the program will expand to 15 additional sites.
Dr. Bero says expanding the program is vital, particularly because Mozambique faces increased risks of climate change-related disease outbreaks.
“[We] are vulnerable to climate change, and when it rains, there are floods,” he says. “If we have the program already established, we can detect if there is cholera or rotavirus or norovirus, or which one is circulating in the community, and which is causing diarrhea. It is extremely important for the country to expand this program.”